ELIEM THERAPEUTICS INC (ELYM) Institutional Ownership Changes & 13F Activity
ELIEM THERAPEUTICS INC (ELYM). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Adage Capital Partners Gp, L.L.C., Cormorant Asset Management, Lp, Frontier Capital Management Co Llc, Woodline Partners Lp, and Braidwell Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +8,395 | +5.4% | 164,712 | $2.15M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +952,309 | +275.5% | 1,297,972 | $16.93M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Buy | +485 | — | 485 | $6.32K | Q2 2026 | Aug 24, 2026 |
| Adage Capital Partners Gp, L.L.C. | Buy | +2,506,000 | — | 2,506,000 | $32.68M | Q2 2026 | Aug 14, 2026 |
| Cormorant Asset Management, Lp | Buy | +2,106,000 | — | 2,106,000 | $27.46M | Q2 2026 | Aug 14, 2026 |
| Frontier Capital Management Co Llc | Buy | +1,939,019 | — | 1,939,019 | $25.28M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +1,582,291 | — | 1,582,291 | $20.63M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Buy | +1,267,700 | +82.9% | 2,797,375 | $36.48M | Q2 2026 | Aug 14, 2026 |
| Redmile Group, Llc | Buy | +1,226,330 | — | 1,226,330 | $15.99M | Q2 2026 | Aug 14, 2026 |
| Stempoint Capital Lp | Buy | +742,745 | — | 742,745 | $9.69M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +657,971 | — | 657,971 | $8.58M | Q2 2026 | Aug 14, 2026 |
| Parkman Healthcare Partners Llc | Buy | +563,484 | — | 563,484 | $7.35M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +373,445 | — | 373,445 | $4.87M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -368,062 | -28.8% | 908,198 | $11.84M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -357,124 | -92.2% | 30,279 | $394.84K | Q2 2026 | Aug 14, 2026 |
| Great Point Partners Llc | Sell | -334,130 | -25.0% | 1,000,000 | $13.04M | Q2 2026 | Aug 14, 2026 |
| Superstring Capital Management Lp | Buy | +321,873 | +161.6% | 521,082 | $6.79M | Q2 2026 | Aug 14, 2026 |
| Ikarian Capital, Llc | Buy | +300,000 | — | 300,000 | $3.91M | Q2 2026 | Aug 14, 2026 |
| Ally Bridge Group (Ny) Llc | Buy | +249,172 | — | 249,172 | $3.25M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +224,987 | +37.6% | 822,649 | $10.73M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +210,313 | +11.0% | 2,127,281 | $27.74M | Q2 2026 | Aug 14, 2026 |
| Driehaus Capital Management Llc | Buy | +189,054 | +31.5% | 790,000 | $10.30M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +162,432 | +155.9% | 266,649 | $3.48M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Sell | -162,368 | -52.3% | 148,238 | $1.93M | Q2 2026 | Aug 14, 2026 |
| Schonfeld Strategic Advisors Llc | Buy | +126,138 | — | 126,138 | $1.64M | Q2 2026 | Aug 14, 2026 |
| Verdad Advisers, Lp | Sell | -98,425 | -68.1% | 46,115 | $601.34K | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Buy | +96,807 | — | 96,807 | $1.26M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +90,348 | +97.9% | 182,645 | $2.38M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +82,583 | +374.5% | 104,634 | $1.36M | Q2 2026 | Aug 14, 2026 |
| Cambria Investment Management, L.P. | Buy | +76,109 | — | 76,109 | $992.46K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about ELYM activity
Which institutional owners are buying ELYM?
Institutional owners buying ELYM include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ELYM activity?
"Buy" means an investor increased their reported position in ELYM compared to the prior reporting period. This reflects growing exposure to ELIEM THERAPEUTICS INC (ELYM) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ELYM increasing?
Institutional interest in ELYM can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.